SCLC: Future Therapies and Advice to Community Oncologists
February 21st 2022Drs Carl M. Gay and Jared Weiss highlight several novel strategies that show promise in optimizing treatment for patients with small cell lung cancer and respond to questions from community oncologists who manage treatment for patients with lung cancer.
Read More
ES-SCLC: Trilaciclib for Chemo-Induced Myelosuppression
September 9th 2021Jared Weiss, MD, of UNC Lineberger Comprehensive Cancer Center, highlights clinical trial data that led to the approval of trilaciclib in patients receiving a chemotherapy-containing regimen for extensive-stage small cell lung cancer.
Read More